Company CVAbout Lasa Supergenerics Ltd 
Lasa Supergenerics Ltd
Micro Cap
Pharmaceuticals & Drugs
Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
Company Coordinates
Company Details
C-105 MIDC, Mahad Raigad Maharashtra : 402301
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 50.10 Cr
Number of Shares
5.01 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Jan-2023
5.01
50.10
9428571
10
Scheme of Amalgamation
30-Nov-2019
4.07
40.67
17808219
10
Loan Conversion
30-Nov-2019
4.07
40.67
17808219
10
Loan Conversion
21-Sep-2017
2.29
22.86
22864449
10
Scheme of Arrangement
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
20.6612
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Omkar Pravin Herleker (53.65%)
Highest Public shareholder
Bnp Enterprises (8.48%)
Individual Investors Holdings
34.11%
Board of Directors
Management
Designation
Remuneration
Omkar P Herlekar
Chairman & Managing Director
0
Shivanand Hedge
Whole-time Director
0
Hardesh Tolani
Independent Director
4.0 lacs
Ajay Sukhwani
Independent Director
3.0 lacs
Ekta Gurnasinghani
Independent Director
4.0 lacs
Mitti M Jain
Company Sec. & Compli. Officer
0
Manali Bhagtani
Independent Director
1.75 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Traded Goods
0.4941
0%
Purchase of Traded Goods
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Chemicals
245.84
100.00%
Chemicals
Stock DNARevenue and Profits:
Net Sales:
33 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
Pharmaceuticals & Drugs
INR 91 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
0.21
-16.17%
0.98
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
